|
||||
|
CA-San Francisco, About the Company Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland and its US headquarters in South San Francisco, CA. Its first drug Tracleer® has been approved as a therapy for pulmonary arterial hypertension and is marketed through subsidiaries in key markets worldwide. As a leading player in innovative science related to the endotheliu
|
||||
| Medical Science Liaison - Southeast Region | ||||